Contravisory Investment Management Inc. Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)


Share on StockTwits

Contravisory Investment Management Inc. raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,764 shares of the healthcare conglomerate’s stock after purchasing an additional 109 shares during the quarter. UnitedHealth Group accounts for approximately 2.2% of Contravisory Investment Management Inc.’s holdings, making the stock its 11th biggest holding. Contravisory Investment Management Inc.’s holdings in UnitedHealth Group were worth $6,931,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Front Barnett Associates LLC raised its holdings in UnitedHealth Group by 3.8% in the 3rd quarter. Front Barnett Associates LLC now owns 37,328 shares of the healthcare conglomerate’s stock valued at $11,638,000 after acquiring an additional 1,381 shares during the last quarter. Aevitas Wealth Management Inc. lifted its holdings in UnitedHealth Group by 18.4% in the 3rd quarter. Aevitas Wealth Management Inc. now owns 2,280 shares of the healthcare conglomerate’s stock worth $711,000 after buying an additional 354 shares in the last quarter. Alley Co LLC purchased a new position in UnitedHealth Group in the 3rd quarter valued at about $204,000. LGT Capital Partners LTD. grew its stake in shares of UnitedHealth Group by 27.6% during the third quarter. LGT Capital Partners LTD. now owns 375,406 shares of the healthcare conglomerate’s stock valued at $117,040,000 after acquiring an additional 81,103 shares in the last quarter. Finally, First Long Island Investors LLC increased its position in shares of UnitedHealth Group by 5.8% during the third quarter. First Long Island Investors LLC now owns 127,463 shares of the healthcare conglomerate’s stock worth $39,739,000 after acquiring an additional 6,996 shares during the last quarter. 86.39% of the stock is currently owned by institutional investors.

In related news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction that occurred on Thursday, December 10th. The stock was sold at an average price of $342.00, for a total value of $855,000.00. Following the completion of the transaction, the director now directly owns 159,487 shares of the company’s stock, valued at approximately $54,544,554. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 7,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 8th. The shares were sold at an average price of $349.78, for a total value of $2,448,460.00. Following the completion of the sale, the director now owns 159,487 shares in the company, valued at $55,785,362.86. The disclosure for this sale can be found here. Over the last quarter, insiders sold 130,253 shares of company stock worth $43,485,730. 0.80% of the stock is currently owned by insiders.

Shares of NYSE UNH traded down $2.33 during mid-day trading on Wednesday, hitting $355.04. The company had a trading volume of 1,958,265 shares, compared to its average volume of 3,410,015. UnitedHealth Group Incorporated has a 12 month low of $187.72 and a 12 month high of $367.95. The stock has a market cap of $336.87 billion, a price-to-earnings ratio of 20.53, a PEG ratio of 1.53 and a beta of 0.68. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.84. The firm’s 50 day simple moving average is $344.91 and its two-hundred day simple moving average is $322.55.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.98 by $0.53. The company had revenue of $65.12 billion for the quarter, compared to analysts’ expectations of $63.97 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period last year, the business posted $3.88 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 16.78 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 15th. Investors of record on Monday, December 7th were issued a $1.25 dividend. The ex-dividend date was Friday, December 4th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.41%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.09%.

A number of brokerages recently commented on UNH. Argus downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, October 19th. Mizuho increased their target price on UnitedHealth Group from $361.00 to $380.00 and gave the company a “buy” rating in a research note on Monday, November 9th. Raymond James lifted their price target on shares of UnitedHealth Group from $355.00 to $405.00 and gave the stock a “strong-buy” rating in a research note on Wednesday, December 2nd. Royal Bank of Canada increased their price objective on shares of UnitedHealth Group from $384.00 to $389.00 and gave the company an “outperform” rating in a research note on Thursday, October 15th. Finally, Barclays raised their price objective on shares of UnitedHealth Group from $322.00 to $365.00 and gave the stock an “overweight” rating in a report on Tuesday, October 13th. Seven equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $383.50.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Featured Story: What is a stock portfolio tracker?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.